康臣药业10月21日斥资417万港元回购26.9万股
Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1 - The company will spend HKD 4.17 million to repurchase 269,000 shares [1]
Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1 - The company will spend HKD 4.17 million to repurchase 269,000 shares [1]